-
-
A third dipetdyl peptidase-4 (dpp-4) inhibitor has been approved by the FDA. Linagliptin follows sitagliptin and saxagliptin to the market. It is marketed by Boehringer Ingelheim as Tradjenta.
-
In a population-based study using hospital discharge diagnosis codes, patients with sleep apnea who underwent knee arthroplasty or open abdominal procedures were more likely to require invasive mechanical ventilation and to be diagnosed with aspiration pneumonia or ARDS than were matched patients without sleep apnea. Knee-replacement patients, but not those undergoing laparotomy, also were more likely to be diagnosed with pulmonary embolism.
-
In the Medicare population, obesity was not associated with mortality, except for those with a BMI of at least 35. However, both overweight and obesity were associated with new or worsening disability within 2 years.
-
In most communities in the United States, hepatitis C (HEPc) treatment is provided by gastroenterologists. Because HEPc is now the most common cause of end-stage liver disease, and unless trends reverse will continue to be so for the foreseeable future, it is important that identification of HEPc infection be continued vigorously in the primary care community, since most at-risk persons see primary care clinicians as their point of initial contact with the health care system.
-
"Sand; tiny, discrete particles with substance but basically without fixed structure, frequently accumulating in forms of great beauty or built into 'castles.' In this elemental form sand, and data, present great danger, able to blind us or even bury us." Walter J Hierholzer, Jr., MD
-
Katrina Crist, MBA, was recently named the new chief executive officer at the Association for Professionals in Infection Control & Epidemiology in Washington, DC.
-
-
With pathogens like Clostridium difficile and multidrug-resistant Acinebactor which can linger on surfaces and fomites for prolonged periods the health care environment is among the top priority research areas to prevent health care associated infections (HAIs).
-
Having finally wrested a seat at the C-suite table, infection preventionists are now poised to move to the patient bedside. A profession that has labored in relative obscurity for much of its existence is at a critical juncture with a host of influential agents who are suddenly very interested in infection prevention: patients, consumer advocates, state and federal regulators. A path to empowerment has opened.
